Abstract
Our previous study demonstrated IL-17-mediated induction of MIP-1α through its binding to the cognate IL-17RA and MIP-1α was involved in astrocyte activation. Transient receptor potential canonical (TRPC) channel was involved in astrocyte activation, however, whether TRPC channel regulates MIP-1α expression in the context of multiple sclerosis (MS) remains largely unknown. In this study we identify the essential role of TRPC channel in IL-17-mediated MIP-1α expression and astrocyte activation. Moreover, treatment of astrocytes with IL-17 activated MAPKs and PI3K/Akt signaling pathways with downstream NF-κB pathways. Interestingly, the TRPC blocker-SKF96365 (10 μM) and Norgestimate (10 μM) significantly inhibited the increased expression of MIP-1α via suppression of IL-17-mediated ERK, p38 and JNK MAPKs and PI3K/Akt pathway activation, thereby underscoring the role of TRPC channel in this process. Together these data underpin the role of TRPC channel as a novel target that regulates MIP-1α expression and cell activation-mediated by IL-17 with implications for therapeutic intervention for reversal of neuroinflammation inflicted by IL-17. Understanding the regulation of MIP-1α expression may provide insights into the development of potential therapeutic targets for neuroinflammation associated with MS.
Similar content being viewed by others
Abbreviations
- TRPC:
-
Transient receptor potential canonical
- MS:
-
Multiple sclerosis
- EAE:
-
Experimental autoimmune encephalomyelitis
- CNS:
-
Central nervous system
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- FBS:
-
Fetal bovine serum
- PVDF:
-
Polyvinylidene difluoride
- TBST:
-
Tris-buffered saline with Tween-20
- GFAP:
-
Glial fibrillary acidic protein
References
Allen NJ, Barres BA (2009) Neuroscience: glia—more than just brain glue. Nature 457:675–677. doi:10.1038/457675a
Aradhya S, Nelson DL (2001) NF-kappaB signaling and human disease. Curr Opin Genet Dev 11:300–306. doi:10.1016/S0959-437X(00)00194-5
Baldwin AS Jr (2001) Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107:3–6. doi:10.1172/JCI11891
Butenko O et al (2012) The increased activity of TRPV4 channel in the astrocytes of the adult rat hippocampus after cerebral hypoxia/ischemia. PLoS ONE 7:e39959. doi:10.1371/journal.pone.0039959
Calderon TM, Eugenin EA, Lopez L, Kumar SS, Hesselgesser J, Raine CS, Berman JW (2006) A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J Neuroimmunol 177:27–39. doi:10.1016/j.jneuroim.2006.05.003
Cao G et al (2013) Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex. Neuropharmacology 67:144–154. doi:10.1016/j.neuropharm.2012.10.020
Chiluiza D, Krishna S, Schumacher VA, Schlondorff J (2013) Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2). J Biol Chem 288:18407–18420. doi:10.1074/jbc.M113.463059
Correale J, Farez MF (2015) The role of astrocytes in multiple sclerosis progression. Front Neurol 6:180. doi:10.3389/fneur.2015.00180
Cortez DM et al (2007) IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta, NF-kappaB, and AP-1 activation. Am J Physiol Heart Circ Physiol 293:H3356–H3365. doi:10.1152/ajpheart.00928.2007
Damann N, Owsianik G, Li S, Poll C, Nilius B (2009) The calcium-conducting ion channel transient receptor potential canonical 6 is involved in macrophage inflammatory protein-2-induced migration of mouse neutrophils. Acta Physiol (Oxf) 195:3–11. doi:10.1111/j.1748-1716.2008.01918.x
Derkow K, Kruger C, Dembny P, Lehnardt S (2015) Microglia induce neurotoxic IL-17 + gammadelta T cells dependent on TLR2, TLR4, and TLR9 activation. PLoS ONE 10:e0135898. doi:10.1371/journal.pone.0135898
Ding N, Zhang Y, Loughran PA, Wang Q, Tsung A, Billiar TR (2013) TIFA upregulation after hypoxia-reoxygenation is TLR4- and MyD88-dependent and associated with HMGB1 upregulation and release. Free Radic Biol Med 63:361–367. doi:10.1016/j.freeradbiomed.2013.05.029
Janssen K, Rickert M, Clarner T, Beyer C, Kipp M (2015) Absence of CCL2 and CCL3 ameliorates central nervous system grey matter but not white matter demyelination in the presence of an intact blood–brain barrier. Mol Neurobiol. doi:10.1007/s12035-015-9113-6
Jia Y, Zhou J, Tai Y, Wang Y (2007) TRPC channels promote cerebellar granule neuron survival. Nat Neurosci 10:559–567. doi:10.1038/nn1870
Kang Z et al (2010) Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32:414–425. doi:10.1016/j.immuni.2010.03.004
Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD (1995) An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155:5003–5010
Kebir H et al (2007) Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation. Nat Med 13:1173–1175. doi:10.1038/nm1651
Kim H, Lee S, Park HC, Lee WH, Lee MS, Suk K (2011) Modulation of glial and neuronal migration by lipocalin-2 in zebrafish. Immune Netw 11:342–347. doi:10.4110/in.2011.11.6.342
Komiyama Y et al (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566–573. doi:10.4049/jimmunol.177.1.566
Li B, Chen S, Zeng S, Luo Q, Li P (2012a) Modeling the contributions of Ca2+ flows to spontaneous Ca2+ oscillations and cortical spreading depression-triggered Ca2+ waves in astrocyte networks. PLoS ONE 7:e48534. doi:10.1371/journal.pone.0048534
Li Y et al (2012b) Taurine attenuates methamphetamine-induced autophagy and apoptosis in PC12 cells through mTOR signaling pathway. Toxicol Lett 215:1–7. doi:10.1016/j.toxlet.2012.09.019
Lim S et al (2015) dNP2 is a blood–brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis. Nat Commun 6:8244. doi:10.1038/ncomms9244
Lock C et al (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500–508. doi:10.1038/nm0502-500
Malarkey EB, Ni Y, Parpura V (2008) Ca2+ entry through TRPC1 channels contributes to intracellular Ca2+ dynamics and consequent glutamate release from rat astrocytes. Glia 56:821–835. doi:10.1002/glia.20656
Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S, Link H (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5:101–104. doi:10.1191/135245899678847275
Mayo L, Quintana FJ, Weiner HL (2012) The innate immune system in demyelinating disease. Immunol Rev 248:170–187. doi:10.1111/j.1600-065X.2012.01135.x
McMahon EJ, Cook DN, Suzuki K, Matsushima GK (2001) Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood–brain barrier. J Immunol 167:2964–2971. doi:10.4049/jimmunol.167.5.2964
Meares GP, Ma X, Qin H, Benveniste EN (2012) Regulation of CCL20 expression in astrocytes by IL-6 and IL-17. Glia 60:771–781. doi:10.1002/glia.22307
Miehe S et al (2012) Inhibition of diacylglycerol-sensitive TRPC channels by synthetic and natural steroids. PLoS ONE 7:e35393. doi:10.1371/journal.pone.0035393
Oksenberg JR, Seboun E, Hauser SL (1996) Genetics of demyelinating diseases. Brain Pathol 6:289–302. doi:10.1111/j.1750-3639.1996.tb00856.x
Peterson LK, Fujinami RS (2007) Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol 184:37–44. doi:10.1016/j.jneuroim.2006.11.015
Potula R et al (2004) Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am J Pathol 165:815–824. doi:10.1016/S0002-9440(10)63344-5
Scimemi A (2013) A TRP among the astrocytes. J Physiol 591:9–15. doi:10.1113/jphysiol.2012.237883
Shibasaki K, Ishizaki Y, Mandadi S (2013) Astrocytes express functional TRPV2 ion channels. Biochem Biophys Res Commun 441:327–332. doi:10.1016/j.bbrc.2013.10.046
Shirakawa H et al (2010) Transient receptor potential canonical 3 (TRPC3) mediates thrombin-induced astrocyte activation and upregulates its own expression in cortical astrocytes. J Neurosci 30:13116–13129. doi:10.1523/JNEUROSCI.1890-10.2010
Singh A, Hildebrand ME, Garcia E, Snutch TP (2010) The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels. Br J Pharmacol 160:1464–1475. doi:10.1111/j.1476-5381.2010.00786.x
Song X, Zhao Y, Narcisse L, Duffy H, Kress Y, Lee S, Brosnan CF (2005) Canonical transient receptor potential channel 4 (TRPC4) co-localizes with the scaffolding protein ZO-1 in human fetal astrocytes in culture. Glia 49:418–429. doi:10.1002/glia.20128
Song M, Chen D, Yu SP (2014) The TRPC channel blocker SKF 96365 inhibits glioblastoma cell growth by enhancing reverse mode of the Na(+)/Ca(2+) exchanger and increasing intracellular Ca(2+). Br J Pharmacol 171:3432–3447. doi:10.1111/bph.12691
Tak PP, Firestein GS (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107:7–11. doi:10.1172/JCI11830
Thippegowda PB, Singh V, Sundivakkam PC, Xue J, Malik AB, Tiruppathi C (2010) Ca2+ influx via TRPC channels induces NF-kappaB-dependent A20 expression to prevent thrombin-induced apoptosis in endothelial cells. Am J Physiol Cell Physiol 298:C656–C664. doi:10.1152/ajpcell.00456.2009
Toghianifar N, Ashtari F, Zarkesh-Esfahani SH, Mansourian M (2015) Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. J Neuroimmunol 285:125–128. doi:10.1016/j.jneuroim.2015.05.022
Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, Fugger L (2008) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172:146–155. doi:10.2353/ajpath.2008.070690
Vazquez G, Wedel BJ, Aziz O, Trebak M, Putney JW Jr (2004) The mammalian TRPC cation channels. Biochim Biophys Acta 1742:21–36. doi:10.1016/j.bbamcr.2004.08.015
Wang J, Lu ZH, Gabius HJ, Rohowsky-Kochan C, Ledeen RW, Wu G (2009) Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J Immunol 182:4036–4045. doi:10.4049/jimmunol.0802981
Wootla B, Eriguchi M, Rodriguez M (2012) Is multiple sclerosis an autoimmune disease? Autoimmune Dis 2012:969657. doi:10.1155/2012/969657
Yan E, Li B, Gu L, Hertz L, Peng L (2013) Mechanisms for L-channel-mediated increase in [Ca(2+)]i and its reduction by anti-bipolar drugs in cultured astrocytes combined with its mRNA expression in freshly isolated cells support the importance of astrocytic L-channels. Cell Calcium 54:335–342. doi:10.1016/j.ceca.2013.08.002
Yao H et al (2009a) Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity. J Neurosci 29:1657–1669. doi:10.1523/JNEUROSCI.2781-08.2009
Yao H, Peng F, Fan Y, Zhu X, Hu G, Buch SJ (2009b) TRPC channel-mediated neuroprotection by PDGF involves Pyk2/ERK/CREB pathway. Cell Death Differ 16:1681–1693. doi:10.1038/cdd.2009.108
Yi H et al (2014) IL-17A induces MIP-1alpha expression in primary astrocytes via Src/MAPK/PI3K/NF-kB pathways: implications for multiple sclerosis. J Neuroimmune Pharmacol 9:629–641. doi:10.1007/s11481-014-9553-1
Zanou N, Schakman O, Louis P, Ruegg UT, Dietrich A, Birnbaumer L, Gailly P (2012) Trpc1 ion channel modulates phosphatidylinositol 3-kinase/Akt pathway during myoblast differentiation and muscle regeneration. J Biol Chem 287:14524–14534. doi:10.1074/jbc.M112.341784
Zeng Z, Leng T, Feng X, Sun H, Inoue K, Zhu L, Xiong ZG (2015) Silencing TRPM7 in mouse cortical astrocytes impairs cell proliferation and migration via ERK and JNK signaling pathways. PLoS ONE 10:e0119912. doi:10.1371/journal.pone.0119912
Zhao N et al (2014) Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of ERK in the nucleus accumbens and caudate putamen in mice. Neuroscience 258:101–110. doi:10.1016/j.neuroscience.2013.11.025
Zhu L, Wu Y, Wei H, Xing X, Zhan N, Xiong H, Peng B (2011) IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: differential involvement of NF-kappaB versus JNK/AP-1 pathways. Mol Immunol 48:647–656. doi:10.1016/j.molimm.2010.11.008
Zou LP et al (1999) Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J Neuroimmunol 98:168–175. doi:10.1016/S0165-5728(99)00100-9
Acknowledgments
This work was supported by grants from the National Natural Science Foundation of China (Nos. 81322048, 81473190), Award for Jiangsu Specially Appointed Professor and the Major State Basic Research Development Program of China (973 Program) (2013CB733800, 2013CB733803). Award for the Open Fund of the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, China (Grant no. KF-GN-201401) and Jiangsu Planned Projects for Postdoctoral Research Funds (Grant no. 1402152C).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Zhang, Y., Huang, R., Zhang, Y. et al. IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel. Inflammopharmacol 24, 33–42 (2016). https://doi.org/10.1007/s10787-015-0256-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-015-0256-x